Professor of Medicine, Stanford University Division of Oncology

Oncology

Kim A. Margolin practices Oncology. She researched medicine at Stanford University School of Medicine. Stanford University School of Medicine is one of the top medical schools in the US. Stanford University School of Medicine is ranked 2/25 in Research/PrimaryCare. She over the years received 1 awards: "Whos Who in Medicine and Healthcare". Kim A. Margolin, MD is also a published doctor. She has 19 paper published. The most recent paper is: Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial. She is registered with Medicare and accepts Medicare payments.

Publications

---

• Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial.
• The High-Dose Aldesleukin "Select" Trial: A Trial to Prospectively Validate Predictive Models of Response Treatment in Patients with Metastatic Renal Cell Carcinoma.
• Hemorrhagic collision metastasis in a cerebral arteriovenous malformation.
• Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic Melanoma: SWOG 0933.
• IntroDuction to the Role of the Immune System in Melanoma.
• Validation and Implementation of Targeted Capture and Sequencing for the Detection of Actionable Mutation, Copy Number Variation, and Gene Rearrangement in Clinical Ca...
• The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma.
• Challenges relating to solid tumour Brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group.
• Ipilimumab in a Phase II trial of melanoma patients with Brain metastases.
• Tumor-Infiltrating Lymphocytes in Melanoma.
• Ipilimumab in patients with melanoma and Brain metastases - Authors' reply.
• BRAF inhibition and beyond in advanced Melanoma.
• Ipilimumab in patients with melanoma and Brain metastases: an open-label, phase 2 trial.
• Temozolomide, thalidomide, and whole Brain radiation therapy for patients with Brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study.
• A single-arm, open-label, expanded access study of vemurafenib in patients with metastatic melanoma in the United States.
• A phase II study of bevacizumab and high-dose interleukin-2 in patients with metastatic renal Cell carcinoma: a Cytokine Working Group (CWG) study.
• Multidisciplinary Approach to Brain Metastasis from Melanoma; Local Therapies for Central Nervous System Metastases.
• Multidisciplinary Approach to Brain Metastasis from Melanoma.

Schools

---

• Stanford University

• Yale

• City Of Hope

• University Of California San Diego

Procedures Preformed

---

• Thoracentesis

Conditions Treated

---

• Acute Leukemia
• Adrenal Gland Cancer
• Anal and Rectal Cancer
• Anemia
• View All

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology

Accepted Insurances

---

Awards

---

• Whos Who in Medicine and Healthcare

Education

---

• City of Hope National Medical Center
• Yale-New Haven Hospital
• Stanford University School of Medicine

Hospital

---

• Stanford Health Care

Drug Facts

---

NPI NUMBER		1912014713
NPPES Provider LastName		MARGOLIN
NPPES Provider FirstName		KIM
NPPES Provider ZIPCode		943055151
NPPES Provider State		CA
Specialty Description		Medical Oncology
Total Claim Count		50.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1912014713
Last Name Of The Provider	MARGOLIN
First Name Of The Provider	KIM
View All

Similar Doctors

---

	Dr. Edmond A. Marzbani, MD This Doctor is OpenDoctor Recommended.
	Dr. Damian J. Green, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Renato G. Martins, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. David M. Aboulafia, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Mehmet F. Fer, MD This Doctor is OpenDoctor Recommended.
	Dr. Kristine J. Rinn, MD This Doctor is OpenDoctor Recommended.
	Dr. Vikramsinh M. Dabhi, MD This Doctor is OpenDoctor Recommended.
	Dr. Bruce E. Clurman, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Ajay K. Gopal, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Zhao Ming Dong, MD
	Dr. H J. Deeg, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Steven J. Collins, MD
	Dr. Forrest M. Stewart, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Jonathan R. Fromm, MD This Doctor is OpenDoctor Recommended.
	Dr. Nicole M. Kuderer, MD This Doctor is OpenDoctor Recommended.
	Dr. Hugh L. Straley, MD This Doctor is OpenDoctor Recommended.
	Dr. Anne C. Silva, MD This Doctor is OpenDoctor Recommended.
	Dr. Marco B. Mielcarek, MD This Doctor is OpenDoctor Recommended.
	Dr. Henry O. Otero, MD
	Dr. Niranjan N. Rathod, MD
	Dr. Jennifer M. Specht, MD This Doctor is OpenDoctor Recommended.
	Laura S. Connelly-Smith, MB BCH This Doctor is OpenDoctor Recommended.
	Dr. Yap-Yee Chong, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog